2025 · 1st Quarter (Jan 1 - Mar 31)

IONIS PHARMACEUTICALS, INC.

Filed by IONIS PHARMACEUTICALS, INC..

Open official filing

Source-reported fields

Filing overview

Type: 1st Quarter - Report
Posted: Apr 16, 2025
Income: Not reported
Expenses: $90,000.00
Registrant: IONIS PHARMACEUTICALS, INC.
Client: IONIS PHARMACEUTICALS, INC.
Filing UUID: 180f0ddf-6e1c-403f-b3b1-6bdd6e8c13dc
Termination date: Not reported

Expense method: A

Literal source text

Lobbying issues and bill citations

HCR · Health Issues

Issues related to the implementation of the Inflation Reduction Act. H.R.1672 - Maintaining Investments in New Innovation Act. H.R.1262/S.932 - Give Kids a Chance Act of 2025. H.R.946 - ORPHAN Cures Act.

Literal federal measure citations: H.R.1672, H.R.1262, S.932, H.R.946

MMM · Medicare/Medicaid

Issues related to the implementation of the Inflation Reduction Act. H.R.1672 - Maintaining Investments in New Innovation Act. H.R.946 - ORPHAN Cures Act.

Literal federal measure citations: H.R.1672, H.R.946

TAX · Taxation/Internal Revenue Code

Issues related to the implementation of the Tax Cuts and Jobs Act of 2017. H.R.1414 - Camerons Law.

Literal federal measure citations: H.R.1414

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.